BPC 157 significantly counteracted an increase in proinflammatory and procachectic cytokines, such as interleukin 6 (IL-6) and TNF-alpha [22] (a similar effect also appeared in rats with bile duct ligation and cirrhosis treated with BPC 157 therapy [118]). Here, IL6 is linked to Cirrhosis.